BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioGeneriX AG 

Janderstasse 3
High-Tech-Park Mannheim
Mannheim    D-68199  Germany
Phone: 49-621-875561-0 Fax: 49-621-87556-33


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Start Up





 Company News
Neose Technologies, Inc. (NTEC) Announces Closing of Asset Sales to Novo Nordisk A/S (NVO) and BioGeneriX AG; First Step in Plan of Liquidation 1/28/2009 6:54:55 AM    More...
Neose Technologies, Inc. (NTEC) to Sell its Assets to Novo Nordisk A/S (NVO) and BioGeneriX AG for $43 Million 9/18/2008 7:07:03 AM    More...
Neose Technologies, Inc. (NTEC) Announces GlycoPEG-GCSF Abstract Accepted for Poster Presentation at IXth World Conference on Clinical Pharmacology and Therapeutics 7/28/2008 10:19:36 AM    More...
BioGeneriX AG and Neose Technologies, Inc. (NTEC) Initiate Phase 2 Trial for GlycoPEG-GCSF 6/23/2008 10:35:53 AM    More...
BioGeneriX AG and Neose Technologies, Inc. (NTEC) Announce Positive Data from Two Phase I Studies of GlycoPEG-GCSF 11/7/2007 10:47:11 AM    More...
BioGeneriX AG and Neose Technologies, Inc. (NTEC) to Host Conference Call to Present GlycoPEG-GCSF Phase I Data 11/1/2007 12:10:12 PM    More...
The Day In Review: BioSimilar Drug Enters Trial 3/21/2007 4:53:46 PM    More...
BioGeneriX AG and Neose Technologies, Inc. (NTEC) Announce Initiation of 2nd Phase I Clinical Trial of GlycoPEG-GCSF; Interim Results From 1st Phase I Trial Show Dose-Dependent Response 3/21/2007 12:37:11 PM    More...
Neose Technologies, Inc. (NTEC) Announces BioGeneriX AG's Initiation Of Phase I Trial Of GlycoPEG-GCSF 11/9/2006 11:29:11 AM    More...
Neose Technologies, Inc. (NTEC) And BioGeneriX AG Announce Second Agreement For A GlycoPEGylated Next-Generation Protein; Milestone Payments Worth Up To $61.5 Million 10/19/2005 5:12:35 PM    More...
12